WEST PHARMACEUTICAL SERVICES INC 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed May 2, 2017
Insider Transaction Report
Form 4
Malone Daniel
Vice President & Controller
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2017-05-02$20.85/sh−4,124$85,985→ 0 totalExercise: $20.85From: 2009-02-26Exp: 2018-02-26→ Common Stock (4,124 underlying) - Exercise/Conversion
Common Stock
2017-05-02$20.85/sh+4,124$85,985→ 33,144.393 total - Sale
Common Stock
2017-05-02$93.31/sh−4,124$384,816→ 29,020.393 total
Footnotes (2)
- [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $93.01 to $93.43, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.